Finance

Lists
Why is NYMXF up 31,25%?
Dive Deeper
NYMXF:OTCMKTS
Nymox Pharmaceutical Corp
0,042 $
+31,25%
(+0,0100) 1D
16 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NYMXF...
Open
0,04 $
High
0,04 $
Low
0,04 $
Mkt. cap
4,71 млн
Avg. vol.
8,07 мың
Volume
1,28 мың
52-wk high
0,20 $
52-wk low
0,00 $
EPS
-0,04 $
Beta
-0,15
Shares outstanding
105,04 млн
No. of employees
3
Open
0,04 $
High
0,04 $
Low
0,04 $
Mkt. cap
4,71 млн
Avg. vol.
8,07 мың
Volume
1,28 мың
52-wk high
0,20 $
52-wk low
0,00 $
EPS
-0,04 $
Beta
-0,15
Shares outstanding
105,04 млн
No. of employees
3
News stories
From web sources and news partners
About Nymox Pharmaceutical Corp
CEO-
Employees3
Founded1989
Headquarters-
Sector-
Websitenymox.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2015 ж. қыр.
2015 ж. жел.
2024 ж. қыр.
2024 ж. жел.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
511,00 м.
624,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
142,00 м.
164,00 м.
Operating expense
-
-
653,00 м.
788,00 м.
Total operating expenses
-
-
653,00 м.
788,00 м.
Operating income
-
-
-653,00 м.
-788,00 м.
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-716,00 м.
-857,00 м.
EBT excluding unusual items
-
-
-716,00 м.
-857,00 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-716,00 м.
-857,00 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
2,00 мың
Interest expense
-
-
-63,00 мың
-86,00 мың
Net interest expenses
-
-
-63,00 мың
-84,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-652,67 м.
-788,00 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары